A detailed history of Legacy Financial Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Legacy Financial Advisors, Inc. holds 3,016 shares of LLY stock, worth $2.26 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
3,016
Previous 2,948 2.31%
Holding current value
$2.26 Million
Previous $2.67 Million 0.07%
% of portfolio
0.52%
Previous 0.53%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$772.14 - $960.02 $52,505 - $65,281
68 Added 2.31%
3,016 $2.67 Million
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $31,894 - $39,997
44 Added 1.52%
2,948 $2.67 Million
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $57,443 - $76,851
97 Added 3.46%
2,904 $2.26 Million
Q4 2023

Feb 06, 2024

BUY
$525.19 - $619.13 $80,879 - $95,346
154 Added 5.8%
2,807 $1.64 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $9,128 - $12,585
21 Added 0.8%
2,653 $1.43 Million
Q2 2023

Aug 08, 2023

SELL
$350.74 - $468.98 $30,865 - $41,270
-88 Reduced 3.24%
2,632 $1.23 Million
Q1 2023

May 03, 2023

SELL
$310.63 - $364.82 $94,431 - $110,905
-304 Reduced 10.05%
2,720 $934,000
Q4 2022

Feb 06, 2023

BUY
$321.55 - $374.67 $393,255 - $458,221
1,223 Added 67.91%
3,024 $1.11 Million
Q3 2022

Nov 09, 2022

BUY
$296.48 - $337.87 $13,638 - $15,542
46 Added 2.62%
1,801 $582,000
Q2 2022

Aug 08, 2022

BUY
$278.73 - $327.27 $39,858 - $46,799
143 Added 8.87%
1,755 $569,000
Q1 2022

May 04, 2022

BUY
$234.69 - $291.66 $19,009 - $23,624
81 Added 5.29%
1,612 $462,000
Q4 2021

Feb 04, 2022

BUY
$224.85 - $279.04 $33,277 - $41,297
148 Added 10.7%
1,531 $423,000
Q3 2021

Oct 26, 2021

SELL
$221.6 - $272.71 $38,115 - $46,906
-172 Reduced 11.06%
1,383 $320,000
Q2 2021

Jul 21, 2021

BUY
$180.55 - $233.54 $26,721 - $34,563
148 Added 10.52%
1,555 $357,000
Q1 2021

Apr 28, 2021

SELL
$164.32 - $212.72 $4,600 - $5,956
-28 Reduced 1.95%
1,407 $263,000
Q4 2020

Feb 02, 2021

SELL
$130.46 - $172.63 $1,174 - $1,553
-9 Reduced 0.62%
1,435 $242,000
Q3 2020

Nov 09, 2020

BUY
$146.22 - $169.13 $211,141 - $244,223
1,444 New
1,444 $214,000
Q2 2019

Aug 07, 2019

SELL
$110.79 - $129.32 $187,235 - $218,550
-1,690 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$111.31 - $131.02 $14,247 - $16,770
128 Added 8.19%
1,690 $219,000
Q4 2018

Jan 16, 2019

BUY
$105.9 - $118.64 $41,195 - $46,150
389 Added 33.16%
1,562 $181,000
Q2 2018

Jul 17, 2018

SELL
$75.7 - $86.88 $177,213 - $203,386
-2,341 Reduced 66.62%
1,173 $105,000
Q1 2018

Apr 12, 2018

BUY
$74.21 - $87.6 $53,876 - $63,597
726 Added 26.04%
3,514 $278,000
Q4 2017

Feb 09, 2018

BUY
$81.94 - $87.89 $228,448 - $245,037
2,788
2,788 $235,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Legacy Financial Advisors, Inc. Portfolio

Follow Legacy Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Legacy Financial Advisors, Inc. with notifications on news.